- Notice convening the annual general meeting in Pharma Equity Group A/S
- Indkaldelse til ordinær generalforsamling i Pharma Equity Group A/S
- Pharma Equity Group A/S (PEG) indgår aftale med Danske Bank om udøvelse af prisstillelse (Market Maker) i PEG aktien, fondskode: DK0061155009
- Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009
- Tegning af konvertible lån fuldført
- Completion of subscription of convertible loans
- Correction: Pharma Equity Group A/S - Årsrapport 2023
- Correction: Pharma Equity Group A/S - Annual Report 2023
- Pharma Equity Groups datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse fra Det Europæiske Patentkontor (EPO) om beslutningen om at tildele deres patent for lægemiddelsammensætninger til fremme af sårheling (RNX-022).
- Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds (RNX-022).
More ▼
Key statistics
On Wednesday, Pharma Equity Group A/S (PEG:CPH) closed at 0.36, 52.54% above the 52 week low of 0.236 set on May 25, 2023.
52-week range
Open | 0.358 |
---|---|
High | 0.364 |
Low | 0.348 |
Bid | -- |
Offer | -- |
Previous close | 0.348 |
Average volume | 528.07k |
---|---|
Shares outstanding | 1.02bn |
Free float | 1.01bn |
P/E (TTM) | -- |
Market cap | 368.27m DKK |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 27 2024 15:26 BST.
More ▼